147 related articles for article (PubMed ID: 34314029)
1. A case of omalizumab as a successful treatment for telangiectasia macularis eruptiva perstans.
Mortimore AM; Barsoum R; Lambie D; McMeniman E
Australas J Dermatol; 2022 Feb; 63(1):102-104. PubMed ID: 34314029
[TBL] [Abstract][Full Text] [Related]
2. Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder.
Martin LK; Romanelli P; Ahn YS; Kirsner RS
Int J Dermatol; 2004 Dec; 43(12):922-4. PubMed ID: 15569020
[TBL] [Abstract][Full Text] [Related]
3. Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.
Michelerio A; Grassi S; Elena C; Croci GA; Boveri E; Bossi G; Brazzelli V
Eur J Dermatol; 2019 Apr; 29(2):174-178. PubMed ID: 30973331
[TBL] [Abstract][Full Text] [Related]
4. Acquired bilateral telangiectasia macularis eruptiva perstans: A unique clinical feature of photodamaging rather than a subtype of cutaneous mastocytosis.
Moon HR; Kim YJ; Jung JM; Won CH; Lee MW; Choi JH; Chang SE
J Dermatol; 2017 Nov; 44(11):1276-1280. PubMed ID: 28646532
[TBL] [Abstract][Full Text] [Related]
5. Telangiectasia macularis eruptive perstans successfully treated with PUVA therapy.
Sotiriou E; Apalla Z; Ioannides D
Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):46-7. PubMed ID: 20070840
[TBL] [Abstract][Full Text] [Related]
6. Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.
Severino M; Chandesris MO; Barete S; Tournier E; Sans B; Laurent C; Apoil PA; Lamant L; Mailhol C; Laroche M; Fraitag S; Hanssens K; Dubreuil P; Hermine O; Paul C; Bulai Livideanu C
J Am Acad Dermatol; 2016 May; 74(5):885-91.e1. PubMed ID: 26899198
[TBL] [Abstract][Full Text] [Related]
7. Unilateral telangiectasia macularis eruptiva perstans of the breast.
Patel N; Stranahan D; Fenske NA
Cutis; 2012 Jul; 90(1):26-8. PubMed ID: 22908729
[TBL] [Abstract][Full Text] [Related]
8. Presentation of telangiectasia macularis eruptiva perstans as a long-standing solitary plaque associated with renal carcinoma.
Pascual JC; Bañuls J; Albares MP; Vergara G; Belinchón I; Silvestre JF; Betlloch I
J Cutan Med Surg; 2003; 7(5):399-402. PubMed ID: 14973646
[TBL] [Abstract][Full Text] [Related]
9. Telangiectasia Macularis Eruptiva Perstans in a 55-Year-Old Female With Type 2 Diabetes Mellitus.
Alhammad NS; Alshehri S; Alawadi TM; Ragaban A; Alyahya FS; Alharbi A
Cureus; 2024 Mar; 16(3):e57333. PubMed ID: 38690480
[TBL] [Abstract][Full Text] [Related]
10. Maculopapular Cutaneous Mastocytosis Successfully Treated with Omalizumab.
Tampouratzi L; Kanni T; Katsantonis J; Douvali T
Acta Dermatovenerol Croat; 2021 Apr; 291(1):60-61. PubMed ID: 34477069
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans.
Barber C; Song EJ
JAAD Case Rep; 2022 Jun; 24():71-73. PubMed ID: 35647249
[No Abstract] [Full Text] [Related]
12. Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases.
Tumer G; Jow T; McElligott S; Schwartz RA; Lambert WC
Skinmed; 2017; 15(3):171-174. PubMed ID: 28705275
[TBL] [Abstract][Full Text] [Related]
13. Two cases of telangiectasia macularis eruptiva perstans demonstrated by immunohistochemistry for c-kit (CD 117).
Lee HW; Jeong YI; Choi JC; Lee MW; Choi JH; Moon KC; Koh JK
J Dermatol; 2005 Oct; 32(10):817-20. PubMed ID: 16361734
[TBL] [Abstract][Full Text] [Related]
14. Telangiectasia Macularis Eruptiva Perstans of the Scalp Mimicking Angiosarcoma.
Lawrence M; Sampson J; Oliver F; Restall P; Mackenzie M
Am J Dermatopathol; 2021 Dec; 43(12):e277-e279. PubMed ID: 34797809
[TBL] [Abstract][Full Text] [Related]
15. JAAD game changers: Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.
Friedman AJ
J Am Acad Dermatol; 2020 Feb; 82(2):530. PubMed ID: 31394139
[No Abstract] [Full Text] [Related]
16. Ringed telangiectasias: an unusual presentation of telangiectasia macularis eruptiva perstans.
Siddique L; Ahrns H; Seiverling E
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29196283
[TBL] [Abstract][Full Text] [Related]
17. Telangiectasia macularis eruptiva perstans: more than skin deep.
Watkins CE; Bokor WB; Leicht S; Youngberg G; Krishnaswamy G
Dermatol Reports; 2011 Jan; 3(1):e12. PubMed ID: 25386256
[TBL] [Abstract][Full Text] [Related]
18. Persistent Facial Flushing in a Patient with Telangiectasia Macularis Eruptiva Perstans: An Unusual but Should Emphasized Clinical Finding.
He X; Wang B; Jia X; Li Y; Yan H; Mu Q; Chen S
Clin Cosmet Investig Dermatol; 2022; 15():1309-1312. PubMed ID: 35847419
[TBL] [Abstract][Full Text] [Related]
19. Telangiectasia macularis eruptiva perstans: an old terminology, still frequently used.
Wilmas K; Wohlmuth-Wieser I; Duvic M
Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469737
[TBL] [Abstract][Full Text] [Related]
20. Dermatoscopic findings in telangiectasia macularis eruptiva perstans.
Unterstell N; Lavorato FG; Nery NS; Mann D; Alves Mde F; Barcauí C
An Bras Dermatol; 2013; 88(4):643-5. PubMed ID: 24068144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
